<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
	<generator>Vivvo CMS 4.1</generator>
	<title>Health News </title>
	<link>http://www.healthcanal.com/</link>
	<description>Health News </description>
	<lastBuildDate></lastBuildDate>
	<ttl>15</ttl>
	<copyright>&amp;copy;2010 Spoonlabs d.o.o.</copyright>
	<image>
		<title>Health News </title>
		<url>http://www.healthcanal.com/files.php?file=Health News from HealthCanal.com</url>
		<link>http://www.healthcanal.com/</link>
	</image>
	
			
				
					<item>
						
							<title>FDA approves new skin cancer drug first tested in Arizona by Scottsdale Healthcare and TGen</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/26147-FDA-approves-new-skin-cancer-drug-first-tested-Arizona-Scottsdale-Healthcare-and-TGen.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Thu, 02 Feb 2012 15:59:00 +0000</pubDate>
							<description>World’s first patient on drug was at the Virginia G. Piper Cancer Center at Scottsdale Healthcare </description>
							<guid isPermaLink="false">426c9c23b741b505740574d106051197</guid>
							
						
					</item>
				
					<item>
						
							<title>UB, Women and Children&#039;s Hospital Played Key Role in Development of new Cystic Fibrosis Drug Approved by FDA</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/26044-Women-and-Childrens-Hospital-Played-Key-Role-Development-new-Cystic-Fibrosis-Drug-Approved-FDA.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Wed, 01 Feb 2012 03:02:00 +0000</pubDate>
							<description>Development provides &amp;quot;proof of concept&amp;quot; for additional drug to treat majority of CF patients, also being studied in Buffalo</description>
							<guid isPermaLink="false">4c1079558f3a048e083d6ec286020904</guid>
							
						
					</item>
				
					<item>
						
							<title>FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/26028-FDA-approves-Gleevec-for-expanded-use-patients-with-rare-gastrointestinal-cancer.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Tue, 31 Jan 2012 18:17:00 +0000</pubDate>
							<description>Confirmatory trials show significantly prolonged survival in patients; drug granted regular approval </description>
							<guid isPermaLink="false">b240e1e016dc090b3bee67ebf52af898</guid>
							
						
					</item>
				
					<item>
						
							<title>FDA approves Kalydeco to treat rare form of cystic fibrosis</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/26015-FDA-approves-Kalydeco-treat-rare-form-cystic-fibrosis.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Tue, 31 Jan 2012 17:22:00 +0000</pubDate>
							<description>
Breakthrough therapy targets defective protein</description>
							<guid isPermaLink="false">56145bab63c3e3a517dd92d3c24d8fff</guid>
							
						
					</item>
				
					<item>
						
							<title>FDA approves Inlyta to treat patients with a type of advanced kidney cancer</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/25929-FDA-approves-Inlyta-treat-patients-with-type-advanced-kidney-cancer.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Sat, 28 Jan 2012 05:10:00 +0000</pubDate>
							<description>
Drug helps keep cancer from progressing</description>
							<guid isPermaLink="false">9dc0d00cb9db7900893600612254ffc3</guid>
							
						
					</item>
				
					<item>
						
							<title>Participants Needed for Night Eating Syndrome Study</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/25860-Participants-Needed-for-Night-Eating-Syndrome-Study.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Thu, 26 Jan 2012 16:32:00 +0000</pubDate>
							<description>Saint Louis University&amp;#039;s Department of Psychology is recruiting subjects to participate in a research study on the effectiveness of a behavioral intervention for the treatment of night eating syndrome or NES.</description>
							<guid isPermaLink="false">97b78cad5583a841a09ffe61c9a3115d</guid>
							
						
					</item>
				
					<item>
						
							<title>80 ethnic minority participants needed for aspirin study</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/25332-ethnic-minority-participants-needed-for-aspirin-study.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Tue, 10 Jan 2012 16:34:00 +0000</pubDate>
							<description>SAN ANTONIO (Jan. 10, 2012) — Can a simple intervention – a baby aspirin a day – extend the time that a senior citizen over the age of 65 is productive and free of disabilities? </description>
							<guid isPermaLink="false">3978133043647a588558e85b35fd8140</guid>
							
						
					</item>
				
					<item>
						
							<title>Low reporting of clinical trial data in key US database, study shows - The University of Nottingham</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/25163-Low-reporting-clinical-trial-data-key-database-study-shows---The-University-Nottingham.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Thu, 05 Jan 2012 12:57:00 +0000</pubDate>
							<description>Many clinical trials in the US are failing to report their findings in a publically available database, despite a recent law that compels them to do so, say researchers at The University of Nottingham. </description>
							<guid isPermaLink="false">42565bf6aacfe5f5d568865a8028f493</guid>
							
						
					</item>
				
					<item>
						
							<title>HIV/AIDS vaccine developed at Western proceeding to human clinical trials</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/24918-HIVAIDS-vaccine-developed-Western-proceeding-human-clinical-trials.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Wed, 21 Dec 2011 15:18:00 +0000</pubDate>
							<description>By Communications Staff  - London, Ontario CANADA –The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.</description>
							<guid isPermaLink="false">f2635f18a7867c8c8d9108b212b837ec</guid>
							
						
					</item>
				
					<item>
						
							<title>Chikungunya vaccine trial begins to enroll participants</title>
							<link>http://www.healthcanal.com/drugs-approvals-trials/24885-Chikungunya-vaccine-trial-begins-enroll-participants.html</link>
							
									
								
							<category>Drugs Approvals and Trials</category>
							<pubDate>Wed, 21 Dec 2011 02:27:00 +0000</pubDate>
							<description>NIH scientists developed experimental vaccine</description>
							<guid isPermaLink="false">3c50fe29291f4da5a5450c4da78e0f42</guid>
							
						
					</item>
				
			
		
</channel>
</rss>
